Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 480 participants.
Also called NCT01189890
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 480 participants
- Sponsor
- Registry
-
NCT01189890
-
- Main results
- Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01189890. Randomized; double masking; primary purpose treatment. Start 2010-08-16 (actual); primary completion 2012-10-31 (actual). Results posted on 2013-06-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- sitagliptin phosphate
- Intervention (Drug)
- Glimepiride
- Intervention (Drug)
- Placebo to Sitagliptin
- Intervention (Drug)
- Placebo to Glimepiride
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01189890- Content hash
4c9b60e6282e7c188b5f82b4f449214d80ec19def9f940e8d7ef807e5eb0ae61